Circadian pattern of ambulatory blood pressure in untreated hypertensive tatients with and without metabolic syndrome

Chronobiology International

Volumn 26, Issue 6, 2009, Pages 1189-1205

  Ayala, Diana E ^a   Hermida, Ramón C ^a   Chayán, Luisa ^b   Mojón, Artemio ^a   Fontao, María J ^a   Fernández, José R ^a  

^a UNIVERSITY OF VIGO   (Spain)

^b Urgencias Sanitarias 061 Galicia   (Spain)

Author keywords

Ambulatory blood pressure monitoring; Circadian rhythm; Essential hypertension; Metabolic syndrome; Pulse pressure

Indexed keywords

FIBRINOGEN; HEMOGLOBIN; URIC ACID;

ACTIMETRY; ADULT; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE MONITORING; CIRCADIAN RHYTHM; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHYSICAL ACTIVITY; PREVALENCE; RISK FACTOR; SEDIMENTATION RATE; SLEEP WAKING CYCLE; SYSTOLIC BLOOD PRESSURE;

ADULT; CIRCADIAN RHYTHM; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 70349140993     PISSN: 07420528     EISSN: 15256073     Source Type: Journal    
DOI: 10.1080/07420520903206294     Document Type: Article

References (52)

1. Asmar R, Vol S, Brisac AM, Tichet J, Topouchian J. (2001). Reference values for clinic pulse pressure in a nonselected population. Am. J. Hypertens. 14:415-418.
2. Baguet JP, Hammer L, Lévy P, Pierre H, Rossini E, Mouret S, Ormezzano O, Mallion JM, Pépin JL. (2005). Night-time and diastolic hypertension are common and underestimated conditions in newly diagnosed apnoeic patients. J. Hypertens. 23:521-527.
3. Bastos JM, Bertoquini S, Polonia J. (2007). Relationship of circadian blood pressure and morning blood pressure surge with the severity of metabolic syndrome in newly diagnosed hypertensives. Rev. Port. Cardiol. 26:731-741.
4. Benetos A, Safar M, Rudnichi A, Smulyan H, Richard JI, Ducimetiere P, Guize L. (1997). Pulse pressure: A predictor of long-term cardiovascular mortality in a French male population. Hypertension 30:1410-1415.
5. Blacher J, Gasowski J, Staessen JA, Girerd X, This L, Liu L, Wang JG, Fagard R, Safar ME. (2000). Pulse pressure-not mean pressure-determines cardiovascular risk in older hypertensive patients. Arch. Med. 160:1085-1089.
6. Brotman DJ, Davidson MB, Boumitri M, Vidt DG. (2008). Impaired diurnal blood pressure variation and all-cause mortality. Am. J. Hypertens. 21:92-97.
7. Cuspidi C, Meani S, Fusi V, Severgnini B, Valerio C, Catini E, Leonetti G, Magrini F, Zanchetti A. (2004a). Metabolic syndrome and target organ damage in untreated essential hypertensives. J. Hypertens. 22:1991-1998.
8. Cuspidi C, Meani S, Fusi V, Severgnini B, Valerio C, Catini E, Sala C, Magrini F, Zanchetti A. (2004b). Is the nocturnal fall in blood pressure reduced in essential hypertensive patients with metabolic syndrome? Blood Press. 13:230-235.
9. Cuspidi C, Meani S, Valerio C, Catini E, Fusi V, Sala C, Zanchetti A. (2005). Metabolic syndrome score and ambulatory blood pressure in untreated essential hypertension. Blood Press. Monit. 10:175-180.
10. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O'Brien E. (2005). Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: The Dublin outcome study. Hypertension 46:156-161.
11. Fernández JR, Hermida RC. (1998). Inferential statistical method for analysis of nonsinusoidal hybrid time series with unequidistant observations. Chronobiol. Int. 15:191-204.
12. Fernández JR, Mojón A, Hermida RC. (2004). Comparison of parameters from rhythmometric models with multiple components on hybrid data. Chronobiol. Int. 21:467-482.
13. Fogari R, Zoppi A, Malamani GD, Lazzari P, Destro M, Corradi L. (1993). Ambulatory blood pressure monitoring in normotensive and hypertensive type 2 diabetes. Prevalence of impaired diurnal blood pressure patterns. Am. J. Hypertens. 6:1-7.
14. Foss CH, Vestbo E, Froland A, Gjessing HJ, Mogensen CE, Damsgaard EM. (2000). Normal blood pressure and preserved diurnal variation in offspring of type 2 diabetic patients characterized by features of the metabolic syndrome: The Fredericia Study. Diabetes Care 23:283-289.
15. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. (1999). Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 100:354-360.
16. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Frauss RM, Savage PJ, Smith SC, Spertus JA, Costa F. (2005). Diagnosis and management of the metabolic syndrome. An American Hearty Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735-2752.
17. Hermida RC. (2007). Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: Rationale and design of the MAPEC study. Chronobiol. Int. 24:749-775.
18. Hermida RC, Calvo C, Ayala DE, Mojón A, López JE. (2002). Relationship between physical activity nd blood pressure in dipper and nondipper hypertensive patients. J. Hypertens. 20:1097-1104.
19. Hermida RC, Calvo C, Ayala DE, Domínguez MJ, Covelo M, Fernández JR, Fontao MJ, López JE. (2004). Administration-time- dependent effects of doxazosin GITS on ambulatory blood pressure of hypertensive subjects. Chronobiol. Int. 21:277-296.
20. Hermida RC, Ayala DE, Calvo C, Portaluppi F, Smolensky MH. (2007a). Chronotherapy of hypertension: Administration-time-dependent effects of treatment on the circadian pattern of blood pressure. Adv. Drug Deliv. Rev. 59:923-939.
21. Hermida RC, Ayala DE, Fernández JR, Calvo C. (2007b). Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. Hypertension 50:715-722.
22. Hermida RC, Calvo C, Ayala DE, López JE, Rodríguez M, Chayán L, Mojón A, Fontao MJ, Fernández JR. (2007c). Dose and administration-time-dependent effects of nifedipine GITS on ambulatory blood pressure in hypertensive subjects. Chronobiol. Int. 24:471-493.
23. Hermida RC, Ayala DE, Mojón A, Chayán L, Domínguez MJ, Fontao MJ, Soler R, Alonso I, Fernández JR. (2008). Comparison of the effects on ambulatory blood pressure of awakening versus bedtime administration of torasemide in essential hypertension. Chronobiol. Int. 25:950-970.
24. Hermida RC, Ayala DE, Chayán L, Mojón A, Fernández JR. (2009a). Administration-time-dependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients. Chron-obiol. Int. 26:61-79.
25. Hermida RC, Chayán L, Ayala DE, Mojón A, Domínguez MJ, Fontao MJ, Soler R, Alonso I, Fernández JR. (2009b). Association of metabolic syndrome and blood pressure non-dipping profile in untreated hypertension. Am. J. Hypertens. 22:307-313.
26. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR, Groop L. (2001). Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683-689.
27. Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. (2005). Ambulatory blood pressure and 10-year risk of cardiovascular and non-cardiovascular mortality. The Ohasama Study. Hypertension 45:240-245.
28. Koga H, Hayashi J, Yamamoto M, Kitamoto K. (2005). Prevention of morning surge of hypertension by the evening administration of carvedilol. Jpn. Med. Assoc. J. 48:398-403.
29. Kotsis V, Stabouli S, Bouldin M, Low A, Toumanidis S, Zakopoulos N. (2005). Impact of obesity on 24-hour ambulatory blood pressure and hypertension. Hypertension 45:602-607.
30. Macchia A, Levantesi G, Borrelli G, Franzosi MG, Maggioni AP, Marfisi RM, Scarano M, Tavazzi L, Tognoni G, Valagussa F, Marchioli R. (2006). A clinically practicable diagnostic score for metabolic syndrome improves its predictivity of diabetes mellitus: The Gruppo Italiano per lo Studio della Sopravvivenza nellÍnfarto miocardico (GISSI)-Prevenzione scoring. Am. Heart J. 151:654.e7-754.e17.
31. Madhavan S, Ooi WL, Cohen H, Alderman MH. (1994). Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension 23:395-401.
32. Mancia G, Bombelli M, Corrao G, Facchetti R, Madotto F, Giannattasio C, Trevano FQ, Grassi G, Zan-chetti A, Sega R. (2007a). Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Asso-ciazioni (PAMELA) Study. Daily life blood pressure, cardiac damage, and prognosis. Hypertension 49:40-47.
33. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker HA.J, Zanchetti A. (2007b). 2007 guidelines for the management of arterial hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 25:1105-1187.
34. Masugata H, Senda S, Goda F, Yoshihara Y, Yoshikawa K, Fujita N, Daikuhara H, Nakamura H, Taoka T, Khono M. (2006). Left ventricular diastolic dysfunction as assessed by echocardiography in metabolic syndrome. Hypertens. Res. 29:897-903.
35. Mule G, Cottone S, Mongiovi R, Cusimano P, Mezzatesta G, Seddio G, Volpe V, Nardi E, Andronico G, Piazza G, Cerasola G. (2006). Influence of metabolic syndrome on aortic stiffness in never treated hypertensive patients. Nutr. Metab. Cardiovasc. Dis. 16:54-59.
36. Mule G, Nardi E, Cottone S, Cusimano P, Incalcaterra F, Palermo A, Giandalia ME, Mezzatesta G, Andronico G, Cerasola G. (2007). Relationship of metabolic syndrome with pulse pressure in patients with essential hypertension. Am. J. Hypertens. 20:197-203.
37. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, Tsuji I, Satoh H, Hisamichi S, Imai Y. (2002). Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: The Ohasama study. J. Hypertens. 20:2183-2189.
38. Ohmori M, Fujimura A. (2005). ACE inhibitors and chronotherapy. Clin. Exp. Hypertens. 2 & 3:179-185.
39. Palaniappan L, Carnethon M, Fortman SP. (2003). Association between microalbuminuria and the metabolic syndrome: NHANES III. Am. J. Hypertens. 16:952-958.
40. Portaluppi F, Touitou Y, Smolensky MH. (2008). Ethical and methodological standards for laboratory and medical biological rhythm research. Chronobiol. Int. 25:999-1016.
41. Ridker PM, Buring JE, Cook NR, Rifai N. (2003). C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. An eight-year follow-up of 14,719 initially healthy American women. Circulation 107:391-397.
42. Rutter MK, McComb JM, Forster J, Brady S, Marshall SM. (2000). Increased left ventricular mass index and nocturnal systolic blood pressure in patients with Type 2 diabetes mellitus and micro-albuminuria. Diabet. Med. 17:321-325.
43. Schillaci G, Pirro M, Vaudo G, Gemelli F, Marchesi S, Porcellati C, Mannarino E. (2004). Prognostic value of the metabolic syndrome in essential hypertension. J. Am. Coll. Cardiol. 43:1817-1822.
44. Schillaci G, Pirro M, Vaudo G, Mannarino MR, Savarese G, Pucci G, Franklin SS, Mannarino E. (2005). Metabolic syndrome is associated with aortic stiffness in untreated essential hypertension. Hypertension 45:1078-1082.
45. Schillaci G, Pirro M, Pucci G, Mannarino MR, Gemelli F, Siepi D, Vaudo G, Mannarino E. (2006). Different impact of the metabolic syndrome on left ventricular structure and function in hypertensive men and women. Hypertension 47:881-886.
46. Staessen JA, Thijs L, Fagard R, ÓBrien ET, Clement D, de Leeuw PW, Mancia G, Nachev C, Palatini P, Parati G, Tuomilehto J, Webster J, for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. (1999). Predicting cardiovascular risk using conventional vs. ambulatory blood pressure in older patients with systolic hypertension. JAMA. 282:539-546.
47. Tartan Z, Uyarel H, Kasikcioglu H, Alper AT, Ozay B, Bilsen T, Gul M, Ozturk R, Cam N. (2006). Metabolic syndrome as a predictor of non-dipping hypertension. Tohoku J. Exp. Med. 210:57-66.
48. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistell M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G. (1994). Ambulatory blood pressure: An independent predictor of prognosis in essential hypertension. Hypertension 24:793-801.
49. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Pede S, Porcellati C. (1998). Ambulatory pulse pressure: A potent predictor of total cardiovascular risk in hypertension. Hypertension 32:983-988.
50. Verdecchia P, Schillaci G, Reboldi G, Franklin SS, Porcellati C. (2001). Different prognostic impact of 24-hour mean blood pressure and pulse pressure on stroke and coronary artery disease in essential hypertension. Circulation 103:2579-2584.
51. Vyssoulis GP, Karpanou EA, Kyvelou SMG, Adamopoulos DN, Deligeorgis AD, Spanos PG, Pietri PG, Cokkinos DF, Stefanadis CI. (2007). Nocturnal blood pressure fall and metabolic syndrome score in hypertensive patients. Blood Press. Monit. 12:351-356.
52. White WB, Mansoor GA, Pickering TG, Vidt DG, Hutchinson HG, Johnson RB, Noveck R. (1999). Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate. Am. J. Hypertens. 12:806-814.